Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Cerevel Therapeutics: Q1 Earnings Insights

 

Cerevel Therapeutics Hldg (NASDAQ:CERE) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.

Earnings

Cerevel Therapeutics Hldg missed estimated earnings by 9.52%, reporting an EPS of $-0.46 versus an estimate of $-0.42.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 6.45% increase in the share price the next day.

 

To track all earnings releases for Cerevel Therapeutics Hldg visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.